NIR‐Activated Multimodal Photothermal/Chemodynamic/Magnetic Resonance Imaging Nanoplatform for Anticancer Therapy by Fe(II) Ions Doped MXenes (Fe‐Ti3C2). Issue 33 (5th July 2021)
- Record Type:
- Journal Article
- Title:
- NIR‐Activated Multimodal Photothermal/Chemodynamic/Magnetic Resonance Imaging Nanoplatform for Anticancer Therapy by Fe(II) Ions Doped MXenes (Fe‐Ti3C2). Issue 33 (5th July 2021)
- Main Title:
- NIR‐Activated Multimodal Photothermal/Chemodynamic/Magnetic Resonance Imaging Nanoplatform for Anticancer Therapy by Fe(II) Ions Doped MXenes (Fe‐Ti3C2)
- Authors:
- Wu, Yizhang
Song, Xueru
Xu, Wei
Sun, Kuo‐yang
Wang, Zhaokun
Lv, Zhongyang
Wang, Yue
Wang, Yong
Zhong, Wei
Wei, Jia
Cai, Hong‐Ling
Wu, Xiaoshan - Abstract:
- Abstract: 2D MXene, Ti3 C2 (TC), has displayed enormous potential in applications in photothermal therapy (PTT), attributing to its biocompatibility and outstanding photothermal conversion capability. However, some tumor ablations are difficult to be realized completely by monotherapy due to the essential defects of monotherapy and intricate tumor microenvironment (TME). In this work, the appropriate doped Fe 2+ ions are anchored into the layers of 2D ultrathin TC nanosheets (TC NSs) to synthesize a novel multifunctional nanoshell of Fe(II)‐Ti3 C2 (FTC) through interlayer electrostatic adsorption. FTC possesses superior photothermal conversion efficiency (PTCE) than TC NSs, attributing to the enhanced conductivity promoted by interlaminar ferrous ion‐channels. Moreover, Fenton reaction based on ferrous ions endows FTC the abilities of reactive oxide species (ROS) releasing and glutathione (GSH) suppression triggered by near‐infrared (NIR) laser, featuring splendid biocompatibility and curative effect in hypoxic TME. Meanwhile, magnetic resonance imaging (MRI) responding in FTC reveals the potential as an integrated diagnosis and treatment nanoplatform. FTC could provide new insights into the development of multimoded synergistic nanoplatform for biological applications, especially breaking the shackles of MXenes merely used as a photo‐thermal agent (PTA), adopting it to bioimaging sensor and drug loading. Abstract : Near‐infrared (NIR) activated multimodal nanoplatformAbstract: 2D MXene, Ti3 C2 (TC), has displayed enormous potential in applications in photothermal therapy (PTT), attributing to its biocompatibility and outstanding photothermal conversion capability. However, some tumor ablations are difficult to be realized completely by monotherapy due to the essential defects of monotherapy and intricate tumor microenvironment (TME). In this work, the appropriate doped Fe 2+ ions are anchored into the layers of 2D ultrathin TC nanosheets (TC NSs) to synthesize a novel multifunctional nanoshell of Fe(II)‐Ti3 C2 (FTC) through interlayer electrostatic adsorption. FTC possesses superior photothermal conversion efficiency (PTCE) than TC NSs, attributing to the enhanced conductivity promoted by interlaminar ferrous ion‐channels. Moreover, Fenton reaction based on ferrous ions endows FTC the abilities of reactive oxide species (ROS) releasing and glutathione (GSH) suppression triggered by near‐infrared (NIR) laser, featuring splendid biocompatibility and curative effect in hypoxic TME. Meanwhile, magnetic resonance imaging (MRI) responding in FTC reveals the potential as an integrated diagnosis and treatment nanoplatform. FTC could provide new insights into the development of multimoded synergistic nanoplatform for biological applications, especially breaking the shackles of MXenes merely used as a photo‐thermal agent (PTA), adopting it to bioimaging sensor and drug loading. Abstract : Near‐infrared (NIR) activated multimodal nanoplatform Fe‐Ti3 C2 (FTC) is developed by electrostatic adsorption between Ti3 C2 and Fe(II). FTC can generate reactive oxygen species (ROS) and suppress glutathione (GSH) under NIR excitation. FTC has the superior photothermal performance than Ti3 C2 . The ferrous ions also endow FTC the ability to serve as a T 1 and T 2 dual‐responding magnetic resonance contrast agent. … (more)
- Is Part Of:
- Small. Volume 17:Issue 33(2021)
- Journal:
- Small
- Issue:
- Volume 17:Issue 33(2021)
- Issue Display:
- Volume 17, Issue 33 (2021)
- Year:
- 2021
- Volume:
- 17
- Issue:
- 33
- Issue Sort Value:
- 2021-0017-0033-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-07-05
- Subjects:
- anticancer therapy -- electrostatic adsorption -- integrated diagnosis and treatment -- NIR activation -- Ti 3C 2 MXene
Nanotechnology -- Periodicals
Nanoparticles -- Periodicals
Microtechnology -- Periodicals
620.5 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1613-6829 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/smll.202101705 ↗
- Languages:
- English
- ISSNs:
- 1613-6810
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8309.952000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18546.xml